产经

订阅

MedSci主页 / 所有栏目 / 产经

306家药企销售费用共花2793亿！8家制药企业超50亿，医疗企业平均花3亿

2020-05-05 米内网 米内网

药企销售费用
关注

306家药企销售费用共花2793亿！8家制药企业超50亿，医疗企业平均花3亿

来源：米内网、东方财富网、上市公司公告

注：统计截至4月30日上午收盘，如有疏漏，欢迎留言补充。
2018年、2019年没有同时公布销售费用情况的企业不纳入统计范围

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1687374, encodeId=596f168e3741d, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Thu Dec 17 23:39:49 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884947, encodeId=516388494ee5, content=还行, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Sun Sep 13 14:21:58 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976720, encodeId=fb6819e6720a4, content=<a href='/topic/show?id=b849966e432' target=_blank style='color:#2F92EE;'>#销售费用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96674, encryptionId=b849966e432, topicName=销售费用)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaP1mV9qBwx5tE2F4xcG1r4x1PibWvluIFLB8VsViakqNMBia2Z0wFibVrYwDEILvHB1OomzzTAAGy5MVl5BrdEv9Bw/132, createdBy=e11f100, createdName=guguangxiang, createdTime=Mon Aug 24 19:39:49 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456303, encodeId=b134145630309, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Thu May 07 02:39:49 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596336, encodeId=4d66159633606, content=<a href='/topic/show?id=31693238980' target=_blank style='color:#2F92EE;'>#制药企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32389, encryptionId=31693238980, topicName=制药企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2c818366159, createdName=listen324, createdTime=Thu May 07 02:39:49 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382511, encodeId=1ab338251183, content=迈瑞净利太厉害！, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue May 05 11:55:05 CST 2020, time=2020-05-05, status=1, ipAttribution=)]
    2020-12-17 1249862am81(暂无昵称)

    #销售#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1687374, encodeId=596f168e3741d, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Thu Dec 17 23:39:49 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884947, encodeId=516388494ee5, content=还行, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Sun Sep 13 14:21:58 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976720, encodeId=fb6819e6720a4, content=<a href='/topic/show?id=b849966e432' target=_blank style='color:#2F92EE;'>#销售费用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96674, encryptionId=b849966e432, topicName=销售费用)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaP1mV9qBwx5tE2F4xcG1r4x1PibWvluIFLB8VsViakqNMBia2Z0wFibVrYwDEILvHB1OomzzTAAGy5MVl5BrdEv9Bw/132, createdBy=e11f100, createdName=guguangxiang, createdTime=Mon Aug 24 19:39:49 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456303, encodeId=b134145630309, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Thu May 07 02:39:49 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596336, encodeId=4d66159633606, content=<a href='/topic/show?id=31693238980' target=_blank style='color:#2F92EE;'>#制药企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32389, encryptionId=31693238980, topicName=制药企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2c818366159, createdName=listen324, createdTime=Thu May 07 02:39:49 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382511, encodeId=1ab338251183, content=迈瑞净利太厉害！, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue May 05 11:55:05 CST 2020, time=2020-05-05, status=1, ipAttribution=)]
    2020-09-13 ms1000000302953060

    还行

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1687374, encodeId=596f168e3741d, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Thu Dec 17 23:39:49 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884947, encodeId=516388494ee5, content=还行, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Sun Sep 13 14:21:58 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976720, encodeId=fb6819e6720a4, content=<a href='/topic/show?id=b849966e432' target=_blank style='color:#2F92EE;'>#销售费用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96674, encryptionId=b849966e432, topicName=销售费用)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaP1mV9qBwx5tE2F4xcG1r4x1PibWvluIFLB8VsViakqNMBia2Z0wFibVrYwDEILvHB1OomzzTAAGy5MVl5BrdEv9Bw/132, createdBy=e11f100, createdName=guguangxiang, createdTime=Mon Aug 24 19:39:49 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456303, encodeId=b134145630309, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Thu May 07 02:39:49 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596336, encodeId=4d66159633606, content=<a href='/topic/show?id=31693238980' target=_blank style='color:#2F92EE;'>#制药企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32389, encryptionId=31693238980, topicName=制药企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2c818366159, createdName=listen324, createdTime=Thu May 07 02:39:49 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382511, encodeId=1ab338251183, content=迈瑞净利太厉害！, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue May 05 11:55:05 CST 2020, time=2020-05-05, status=1, ipAttribution=)]
    2020-08-24 guguangxiang

    #销售费用#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1687374, encodeId=596f168e3741d, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Thu Dec 17 23:39:49 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884947, encodeId=516388494ee5, content=还行, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Sun Sep 13 14:21:58 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976720, encodeId=fb6819e6720a4, content=<a href='/topic/show?id=b849966e432' target=_blank style='color:#2F92EE;'>#销售费用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96674, encryptionId=b849966e432, topicName=销售费用)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaP1mV9qBwx5tE2F4xcG1r4x1PibWvluIFLB8VsViakqNMBia2Z0wFibVrYwDEILvHB1OomzzTAAGy5MVl5BrdEv9Bw/132, createdBy=e11f100, createdName=guguangxiang, createdTime=Mon Aug 24 19:39:49 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456303, encodeId=b134145630309, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Thu May 07 02:39:49 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596336, encodeId=4d66159633606, content=<a href='/topic/show?id=31693238980' target=_blank style='color:#2F92EE;'>#制药企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32389, encryptionId=31693238980, topicName=制药企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2c818366159, createdName=listen324, createdTime=Thu May 07 02:39:49 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382511, encodeId=1ab338251183, content=迈瑞净利太厉害！, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue May 05 11:55:05 CST 2020, time=2020-05-05, status=1, ipAttribution=)]
    2020-05-07 hyf030

    #企业#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1687374, encodeId=596f168e3741d, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Thu Dec 17 23:39:49 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884947, encodeId=516388494ee5, content=还行, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Sun Sep 13 14:21:58 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976720, encodeId=fb6819e6720a4, content=<a href='/topic/show?id=b849966e432' target=_blank style='color:#2F92EE;'>#销售费用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96674, encryptionId=b849966e432, topicName=销售费用)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaP1mV9qBwx5tE2F4xcG1r4x1PibWvluIFLB8VsViakqNMBia2Z0wFibVrYwDEILvHB1OomzzTAAGy5MVl5BrdEv9Bw/132, createdBy=e11f100, createdName=guguangxiang, createdTime=Mon Aug 24 19:39:49 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456303, encodeId=b134145630309, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Thu May 07 02:39:49 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596336, encodeId=4d66159633606, content=<a href='/topic/show?id=31693238980' target=_blank style='color:#2F92EE;'>#制药企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32389, encryptionId=31693238980, topicName=制药企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2c818366159, createdName=listen324, createdTime=Thu May 07 02:39:49 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382511, encodeId=1ab338251183, content=迈瑞净利太厉害！, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue May 05 11:55:05 CST 2020, time=2020-05-05, status=1, ipAttribution=)]
    2020-05-07 listen324

    #制药企业#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1687374, encodeId=596f168e3741d, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Thu Dec 17 23:39:49 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884947, encodeId=516388494ee5, content=还行, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Sun Sep 13 14:21:58 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976720, encodeId=fb6819e6720a4, content=<a href='/topic/show?id=b849966e432' target=_blank style='color:#2F92EE;'>#销售费用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96674, encryptionId=b849966e432, topicName=销售费用)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaP1mV9qBwx5tE2F4xcG1r4x1PibWvluIFLB8VsViakqNMBia2Z0wFibVrYwDEILvHB1OomzzTAAGy5MVl5BrdEv9Bw/132, createdBy=e11f100, createdName=guguangxiang, createdTime=Mon Aug 24 19:39:49 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456303, encodeId=b134145630309, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Thu May 07 02:39:49 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596336, encodeId=4d66159633606, content=<a href='/topic/show?id=31693238980' target=_blank style='color:#2F92EE;'>#制药企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32389, encryptionId=31693238980, topicName=制药企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2c818366159, createdName=listen324, createdTime=Thu May 07 02:39:49 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382511, encodeId=1ab338251183, content=迈瑞净利太厉害！, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue May 05 11:55:05 CST 2020, time=2020-05-05, status=1, ipAttribution=)]
    2020-05-05 lovetcm

    迈瑞净利太厉害！

    0

相关资讯

跨国药企业2019年报深度分析

冬去春又来，又是一年一度的业绩披露季。全球头部跨国药企陆续发布年报。根据公开资料显示，所统计的17家跨国药企2019年合计业务收入超过4800亿美元。其中排在前三甲的是强生、罗氏和辉瑞。

2020 Q1各大药企收入排名，强生，罗氏，诺华，默沙东，辉瑞，礼来，阿斯利康......

4月份，强生，礼来，GSK，辉瑞、诺华、默沙东相继发布了2020年第一季度财报。在疫情的笼罩之下，今年注定是不平凡的一年。而对于跨国药企而言，其开年业绩就上演了“王座更迭”的戏

已有药企开始降薪

部分药企，已经开始降薪

重磅！国税总局发文：一批药企享税收优惠

医药企业注意，刚刚，国家税务总局发布多项税费优惠政策——其中，对疫情防控重点保障物资生产企业全额退还增值税增量留抵税额。

药企降薪、裁员，仅是受疫情影响吗？

重磅数据，终于公布了！

一批药企，转向器械

近期，一些药企开始加码医疗器械相关业务，医疗器械前景被看好